Full article: Animal models of obsessive compulsive disorder: recent findings and future directions
κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition | Neuropsychopharmacology
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach. - Abstract - Europe PMC
PDF) Are 5-HT 3 antagonists effective in obsessive-compulsive disorder? A systematic review of literature | Carlotta Gasperoni and Daria Piacentino - Academia.edu
Opioid receptors: distinct roles in mood disorders. - Abstract - Europe PMC
Brain Sciences | Free Full-Text | Adolescent Intermittent Ethanol Exposure Effects on Kappa Opioid Receptor Mediated Dopamine Transmission: Sex and Age of Exposure Matter
Lithium: a potential therapeutic strategy in obsessive–compulsive disorder by targeting the canonical WNT/β pathway | Translational Psychiatry
The secrets of kratom - Interview with Jay McLaughlin - Blossom
Brain Sciences | Free Full-Text | Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents
Mu Opioid Receptor Antagonists: Recent Developments - Goodman - 2007 - ChemMedChem - Wiley Online Library
An Adenosine A2A Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis | eNeuro
Drug and Non-drug Treatment of Tourette Syndrome | Bentham Science
Computational insights on asymmetrical $$D_{1}$$ and $$D_{2}$$ receptor-mediated chunking: implications for OCD and Schizophrenia | SpringerLink
Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy - ScienceDirect
N‐acetylcysteine as a new prominent approach for treating psychiatric disorders - Smaga - 2021 - British Journal of Pharmacology - Wiley Online Library
PDF) Dynorphin and the Kappa Opioid Receptor's Role in the Symptomatology of Schizophrenia: A Review of the Evidence
Kappa-Opioid Agonist U69593 Potentiates Locomotor Sensitization to the D2/D3 Agonist Quinpirole: Pre- and Postsynaptic Mechanisms | Neuropsychopharmacology
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach | Iranian Journal of Pharmaceutical Research | Full Text
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents
Back to the Future: Circuit-testing TS & OCD - ScienceDirect
Social interaction modulates the intensity of compulsive checking in a rat model of obsessive-compulsive disorder (OCD) | Semantic Scholar
